[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

about

Cytokine-induced killer cell therapy for modulating regulatory T cells in patients with non-small cell lung cancer

P2860

Q41016369-A75750FF-3CC6-48A4-9313-7BA150D4C022

P2860

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

Item

http://www.wikidata.org/entity/Q55427825

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@en

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@nl

type

Item

label

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@en

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@nl

prefLabel

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@en

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@nl

P1476

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

@en

P2093

Jiawei Tian

http://www.w3.org/2001/XMLSchema#string

Shuhua Han

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancer

Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012

ERCC1 isoform expression and DNA repair in non-small-cell lung cancer.

Expression of ERCC1, RRM1 and LRP in non-small cell lung cancers and their influence on chemotherapeutic efficacy of gemcitabine concomitant with nedaplatin.

RRM1 expression and clinical outcome of gemcitabine-containing chemotherapy for advanced non-small-cell lung cancer: a meta-analysis.

A prospective study of biomarker-guided chemotherapy in patients with non-small cell lung cancer

ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform

A small-molecule blocking ribonucleotide reductase holoenzyme formation inhibits cancer cell growth and overcomes drug resistance

Response to first-line chemotherapy in patients with non-small cell lung cancer according to RRM1 expression.

Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis

P304

381-386

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3779/J.ISSN.1009-3419.2015.06.09

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26104896

http://www.w3.org/2001/XMLSchema#string

P932

5999903

http://www.w3.org/2001/XMLSchema#string

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

about

P2860

P2860

[Role of RRM1 in the Treatment and Prognosis of Advanced Non-small Cell Lung Cancer].

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932